We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DDMAC Warns AstraZeneca Over Crestor Promotion
DDMAC Warns AstraZeneca Over Crestor Promotion
March 18, 2005
AstraZeneca has received its second untitled letter in four months from the FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) regarding promotional activities for the company’s cholesterol-lowering drug Crestor.